Frankfurt - Delayed Quote EUR

Ascelia Pharma AB (7ZA.F)

0.2805
-0.0455
(-12.25%)
As of 8:03:30 AM GMT+2. Market Open.
Loading Chart for 7ZA.F
  • Previous Close 0.3260
  • Open 0.2805
  • Bid --
  • Ask --
  • Day's Range 0.2805 - 0.2805
  • 52 Week Range 0.1110 - 0.9010
  • Volume 2,754
  • Avg. Volume 1,145
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 7ZA.F

View More

Performance Overview: 7ZA.F

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

7ZA.F
44.59%
OMX Stockholm 30 Index (^OMX)
2.38%

1-Year Return

7ZA.F
65.16%
OMX Stockholm 30 Index (^OMX)
2.55%

3-Year Return

7ZA.F
85.27%
OMX Stockholm 30 Index (^OMX)
26.83%

5-Year Return

7ZA.F
93.86%
OMX Stockholm 30 Index (^OMX)
70.21%

Compare To: 7ZA.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7ZA.F

View More

Valuation Measures

Annual
As of 5/14/2025
  • Market Cap

    33.79M

  • Enterprise Value

    29.20M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    4.47

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 7ZA.F

View More

Company Insights: 7ZA.F

Research Reports: 7ZA.F

View More